Haematology guidance available now
UK-focused educational guidance for clinicians, organised by clinical area and linked directly to the complete resource. Published material is separated clearly from work under governance review.
Published resources
Guidance and evidence summaries for lymphoid malignancies, with version and source information on each resource page.
Chronic Lymphocytic Leukaemia
MBL distinction, iwCLL active-disease criteria, staging, molecular work-up, treatment pathways, relapsed disease, Richter transformation and supportive care.
PublishedMultiple Myeloma
UK-focused educational guidance across precursor states, newly diagnosed and relapsed disease, supportive care and survivorship.
PublishedMantle Cell Lymphoma
Evidence-first diagnostic and treatment pathways with explicit England access labels, separate devolved-nation notes and controlled downloadable resources.
BetaHodgkin Lymphoma
Age-aware educational pathways for classical Hodgkin lymphoma and NLPHL, covering diagnosis, staging, first-line and relapsed disease, with efficacy separated from England access.
Anaemia in pregnancy
A complete resource package with the main guideline, practical pathways and downloadable teaching and audit material.
Anaemia in Pregnancy
Trimester haemoglobin thresholds, ferritin interpretation, oral and intravenous iron principles, postpartum management and transfusion considerations.
DownloadOne-page quick reference
A concise bedside summary supplied with the full anaemia-in-pregnancy resource package.
Audit resourceAudit workbook
A downloadable workbook to support local review of practice against the educational guideline.
Decision-focused guidance
Structured resources for common and high-risk clinical questions in thrombosis and immune thrombocytopenia.
Cancer-Associated Thrombosis
Anticoagulant selection, risk stratification, duration of therapy, recurrent VTE and thromboprophylaxis decisions in active malignancy.
PublishedITP in Adults
Diagnosis of exclusion, treatment thresholds, first-line therapy, TPO receptor agonists, splenectomy and emergency bleeding management.
Evidence reviewExtended Anticoagulation after Unprovoked VTE
A structured critical appraisal focused on balancing recurrent thrombosis against bleeding risk.
These resources support, but do not replace, local policy, senior clinical judgement, prescribing checks and patient-specific assessment. See the clinical governance statement.